Clover Health Investments Corp ( (CLOV)) has released its Q3 earnings. Here is a breakdown of the information Clover Health Investments Corp presented to its investors. Clover Health Investments ...

Full Year 2024 Adjusted EBITDA Guidance: Increased to between $55 million and $65 million. Clover Health Investments Corp (NASDAQ:CLOV) reported another quarter of meaningful adjusted EBITDA ...

Medicare Advantage insurer Clover Health believes its AI assistant platform has positioned the company toward success next year. Just months after its first quarterly net profit, Clover posted a ...

Ladies and gentlemen, good afternoon, and welcome to the Clover Health Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer ...

Third Quarter 2024 Conference Call and Webcast Details: What: Clover Health’s Third Quarter 2024 Earnings Conference Call When: Wednesday, November 6, 2024, at 5:00 p.m. Eastern Time Dial In: To ...

Clover Health's pivot to profitability over growth following the divestiture of the non-insurance segment at the end of 2023 has led to significant earnings improvements. The newly launched ...

Clover Health Investments, Corp. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.04. Operator: Ladies and gentlemen, good afternoon, and welcome to the Clover Health ...

Canaccord analyst Richard Close raised the firm’s price target on Clover Health (CLOV) to $4.20 from $3.20 and keeps a Buy rating on the shares. The firm said although 3Q results were mixed ...

Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today ...

Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the third quarter 2024.